ZA201305497B - Methods and compositions for preventing and treating osteoarthritis - Google Patents

Methods and compositions for preventing and treating osteoarthritis

Info

Publication number
ZA201305497B
ZA201305497B ZA2013/05497A ZA201305497A ZA201305497B ZA 201305497 B ZA201305497 B ZA 201305497B ZA 2013/05497 A ZA2013/05497 A ZA 2013/05497A ZA 201305497 A ZA201305497 A ZA 201305497A ZA 201305497 B ZA201305497 B ZA 201305497B
Authority
ZA
South Africa
Prior art keywords
compositions
preventing
methods
treating osteoarthritis
osteoarthritis
Prior art date
Application number
ZA2013/05497A
Other languages
English (en)
Inventor
Rondo Paul Middleton
Mark Kenneth Waldron
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of ZA201305497B publication Critical patent/ZA201305497B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2013/05497A 2010-12-21 2013-07-19 Methods and compositions for preventing and treating osteoarthritis ZA201305497B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
ZA201305497B true ZA201305497B (en) 2015-01-28

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/05497A ZA201305497B (en) 2010-12-21 2013-07-19 Methods and compositions for preventing and treating osteoarthritis

Country Status (11)

Country Link
US (1) US20140205569A1 (https=)
EP (1) EP2654744A4 (https=)
JP (1) JP2014505679A (https=)
CN (1) CN103384521A (https=)
AU (1) AU2011349718B2 (https=)
BR (1) BR112013018453A2 (https=)
CA (1) CA2822263A1 (https=)
MX (1) MX2013007191A (https=)
RU (1) RU2013133998A (https=)
WO (1) WO2012087745A1 (https=)
ZA (1) ZA201305497B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
DE69633818T2 (de) * 1995-08-07 2005-12-08 Suntory Ltd. Verwendung eines mittels zur zur vorbeugung oder behandlung von durch anomalitäten des knorpelgewebes verursachten erkrankungen
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
DE60119515T2 (de) * 2000-05-25 2007-05-24 Société des Produits Nestlé S.A. Probiotica für verwendung als haustierfutter
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
DK1656130T3 (da) * 2003-08-11 2008-11-24 Hills Pet Nutrition Inc Omega-3-fedtsyrer til behandling af osteoarthritis hos hunde
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
ES2998457T3 (en) * 2003-11-21 2025-02-20 Nestle Sa Food composition comprising glucosamine
CN1997425B (zh) * 2004-07-01 2010-10-13 雀巢技术公司 犬骨关节炎饮食配方
EP3581178B1 (en) * 2005-02-14 2023-08-30 Suntory Holdings Limited Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
AU2007233684A1 (en) * 2006-04-03 2007-10-11 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same

Also Published As

Publication number Publication date
WO2012087745A1 (en) 2012-06-28
US20140205569A1 (en) 2014-07-24
CN103384521A (zh) 2013-11-06
BR112013018453A2 (pt) 2018-05-22
MX2013007191A (es) 2013-07-12
JP2014505679A (ja) 2014-03-06
EP2654744A1 (en) 2013-10-30
CA2822263A1 (en) 2012-06-28
AU2011349718B2 (en) 2017-02-09
RU2013133998A (ru) 2015-01-27
AU2011349718A1 (en) 2013-07-04
EP2654744A4 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
SG10201500124VA (en) Methods and Compositions for Treating Cancer
ZA201302625B (en) Methods and compositions for treating hemophilia b
IL239918A0 (en) Preparations for the treatment of colitis
IL227429A0 (en) The components and methods of cancer treatment
IL224390B (en) Compositions and methods for targeted thermal modulation
EP2655334A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
IL218987A0 (en) Methods and compositions for treating cancer
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
IL238416A0 (en) Preparations and methods for the treatment of diseases caused by protein pathology
ZA201303423B (en) Compositions and methods for treating myelofibrosis
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
ZA201101055B (en) Compositions and methods for treating osteoarthritis
IL215932A0 (en) Compositions and methods for treating burns
ZA201404187B (en) Compositions and methods for treating dental conditions
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
IL216146A0 (en) Methods and compositions for treating lupus
GB201003531D0 (en) Composition and method
IL229231A0 (en) Preparations and methods for the treatment of cancer
GB201018650D0 (en) Methods and compositions
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
GB2500357B (en) Combination and composition for treating obesity
IL225959A0 (en) Methods and preparations for diagnosis and treatment @ בסרטן
EP2632494A4 (en) METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING CANCER
IL220796A0 (en) Compositions and methods for treating gliblastoma gbm